Please provide your email address to receive an email when new articles are posted on . Patients with abnormalities in trabecular and cortical microarchitecture may be at higher risk for complications ...
Romosozumab for 12 months followed by alendronate for 24 months leads to greater improvements in lumbar spine bone density and trabecular bone scores than alendronate alone for 36 months in ...
Please provide your email address to receive an email when new articles are posted on . Postmenopausal women with osteoporosis receiving romosozumab for 12 months had larger improvements in bone ...
Romosozumab significantly increases bone mineral density and bone content compared with teriparatide
A new study shows that in postmenopausal women with low bone mass, romosozumab significantly increased bone mineral density and bone content in both the spine and hip compared to baseline, and also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback